Cargando…

The European mesothelioma epidemic

Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Peto, J, Decarli, A, Vecchia, C La, Levi, F, Negri, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362439/
https://www.ncbi.nlm.nih.gov/pubmed/10027347
http://dx.doi.org/10.1038/sj.bjc.6690105
_version_ 1782153454071840768
author Peto, J
Decarli, A
Vecchia, C La
Levi, F
Negri, E
author_facet Peto, J
Decarli, A
Vecchia, C La
Levi, F
Negri, E
author_sort Peto, J
collection PubMed
description Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945–50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990–94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries. © 1999 Cancer Research Campaign
format Text
id pubmed-2362439
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23624392009-09-10 The European mesothelioma epidemic Peto, J Decarli, A Vecchia, C La Levi, F Negri, E Br J Cancer Regular Article Projections for the period 1995–2029 suggest that the number of men dying from mesothelioma in Western Europe each year will almost double over the next 20 years, from 5000 in 1998 to about 9000 around 2018, and then decline, with a total of about a quarter of a million deaths over the next 35 years. The highest risk will be suffered by men born around 1945–50, of whom about 1 in 150 will die of mesothelioma. Asbestos use in Western Europe remained high until 1980, and substantial quantities are still used in several European countries. These projections are based on the fit of a simple age and birth cohort model to male pleural cancer mortality from 1970 to 1989 for six countries (Britain, France, Germany, Italy, The Netherlands and Switzerland) which together account for three-quarters of the population of Western Europe. The model was tested by comparing observed and predicted numbers of deaths for the period 1990–94. The ratio of mesothelioma to recorded pleural cancer mortality has been 1.6:1 in Britain but was assumed to be 1:1 in other countries. © 1999 Cancer Research Campaign Nature Publishing Group 1999-02 /pmc/articles/PMC2362439/ /pubmed/10027347 http://dx.doi.org/10.1038/sj.bjc.6690105 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Peto, J
Decarli, A
Vecchia, C La
Levi, F
Negri, E
The European mesothelioma epidemic
title The European mesothelioma epidemic
title_full The European mesothelioma epidemic
title_fullStr The European mesothelioma epidemic
title_full_unstemmed The European mesothelioma epidemic
title_short The European mesothelioma epidemic
title_sort european mesothelioma epidemic
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362439/
https://www.ncbi.nlm.nih.gov/pubmed/10027347
http://dx.doi.org/10.1038/sj.bjc.6690105
work_keys_str_mv AT petoj theeuropeanmesotheliomaepidemic
AT decarlia theeuropeanmesotheliomaepidemic
AT vecchiacla theeuropeanmesotheliomaepidemic
AT levif theeuropeanmesotheliomaepidemic
AT negrie theeuropeanmesotheliomaepidemic
AT petoj europeanmesotheliomaepidemic
AT decarlia europeanmesotheliomaepidemic
AT vecchiacla europeanmesotheliomaepidemic
AT levif europeanmesotheliomaepidemic
AT negrie europeanmesotheliomaepidemic